| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy
|
LIJFERING, W. M.
|
|
2006
|
4 |
9 |
p. 1928-1930
|
artikel
|
| 2 |
A comparison of the β-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis
|
TOOMEY, J. R.
|
|
2006
|
4 |
9 |
p. 1989-1996
|
artikel
|
| 3 |
A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990–1999
|
HEERINGA, J.
|
|
2006
|
4 |
9 |
p. 1944-1949
|
artikel
|
| 4 |
Angiogenin: a review of the pathophysiology and potential clinical applications
|
TELLO-MONTOLIU, A.
|
|
2006
|
4 |
9 |
p. 1864-1874
|
artikel
|
| 5 |
Announcements
|
|
|
2006
|
4 |
9 |
p. 2101
|
artikel
|
| 6 |
A prospective replication study of five gene variants previously associated with risk of myocardial infarction
|
ZEE, R. Y. L.
|
|
2006
|
4 |
9 |
p. 2093-2095
|
artikel
|
| 7 |
Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: no
|
KARKOUTI, K.
|
|
2006
|
4 |
9 |
p. 1879-1881
|
artikel
|
| 8 |
Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: yes
|
LEVY, J. H.
|
|
2006
|
4 |
9 |
p. 1875-1878
|
artikel
|
| 9 |
Arterial disease and venous thrombosis: are they related, and if so, what should we do about it?
|
LOWE, G. D. O.
|
|
2006
|
4 |
9 |
p. 1882-1885
|
artikel
|
| 10 |
Assessment of hemostasis through the retrospectroscope
|
WEISKOPF, R. B.
|
|
2006
|
4 |
9 |
p. 2074-2078
|
artikel
|
| 11 |
Barriers to the long-term use of low-molecular weight heparins for treatment of cancer-associated thrombosis
|
WITTKOWSKY, A. K.
|
|
2006
|
4 |
9 |
p. 2090-2091
|
artikel
|
| 12 |
Bioavailability and relative tissue distribution of [125I]-recombinant human thrombin following intravenous or subcutaneous administration to non-human primates
|
VISICH, J. E.
|
|
2006
|
4 |
9 |
p. 1962-1968
|
artikel
|
| 13 |
Blood platelets activate the classical pathway of human complement
|
PEERSCHKE, E. I. B.
|
|
2006
|
4 |
9 |
p. 2035-2042
|
artikel
|
| 14 |
Cholesteryl ester transfer protein genotypes associated with venous thrombosis and dyslipoproteinemia in males
|
PECHENIUK, N. M.
|
|
2006
|
4 |
9 |
p. 2080-2082
|
artikel
|
| 15 |
Circulating tissue factor accumulates in thrombi, but not in hemostatic plugs
|
HOFFMAN, M.
|
|
2006
|
4 |
9 |
p. 2092-2093
|
artikel
|
| 16 |
Distinct antithrombotic consequences of platelet glycoprotein Ibα and VI deficiency in a mouse model of arterial thrombosis
|
KONSTANTINIDES, S.
|
|
2006
|
4 |
9 |
p. 2014-2021
|
artikel
|
| 17 |
Duration of symptoms and D-dimer testing in the ruling-out of venous thromboembolism
|
DE BASTOS, M.
|
|
2006
|
4 |
9 |
p. 2079-2080
|
artikel
|
| 18 |
Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice
|
WANG, X.
|
|
2006
|
4 |
9 |
p. 1982-1988
|
artikel
|
| 19 |
Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry
|
MONREAL, M.
|
|
2006
|
4 |
9 |
p. 1950-1956
|
artikel
|
| 20 |
Female hemophilia A heterozygous for a de novo frameshift and a novel missense mutation of factor VIII
|
CAI, X.-H.
|
|
2006
|
4 |
9 |
p. 1969-1974
|
artikel
|
| 21 |
Forthcoming articles in the October issue
|
|
|
2006
|
4 |
9 |
p. xiv
|
artikel
|
| 22 |
Hemostasis in chronic liver disease
|
TRIPODI, A.
|
|
2006
|
4 |
9 |
p. 2064-2065
|
artikel
|
| 23 |
Hemostasis in chronic liver disease
|
LAFFI, G.
|
|
2006
|
4 |
9 |
p. 2068-2069
|
artikel
|
| 24 |
Hemostasis in chronic liver disease
|
LISMAN, T.
|
|
2006
|
4 |
9 |
p. 2061-2062
|
artikel
|
| 25 |
Hemostasis in chronic liver disease
|
LISMAN, T.
|
|
2006
|
4 |
9 |
p. 2062-2063
|
artikel
|
| 26 |
Hemostasis in chronic liver disease
|
LISMAN, T.
|
|
2006
|
4 |
9 |
p. 2059-2060
|
artikel
|
| 27 |
Hemostasis in chronic liver disease
|
VIOLI, F.
|
|
2006
|
4 |
9 |
p. 2065-2066
|
artikel
|
| 28 |
Hemostasis in chronic liver disease
|
MATSUSHITA, T.
|
|
2006
|
4 |
9 |
p. 2066-2067
|
artikel
|
| 29 |
Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23 796 consecutive autopsies
|
ELIASSON, Å.
|
|
2006
|
4 |
9 |
p. 1897-1902
|
artikel
|
| 30 |
In vitro characterization of missense mutations associated with quantitative protein S deficiency
|
OKADA, H.
|
|
2006
|
4 |
9 |
p. 2003-2009
|
artikel
|
| 31 |
Megakaryocyte polyploidization is associated with decreased expression of polo-like kinase (PLK)
|
YAGI, M.
|
|
2006
|
4 |
9 |
p. 2028-2034
|
artikel
|
| 32 |
Molecular weight fibrinogen variants determine angiogenesis rate in a fibrin matrix in vitro and in vivo
|
KAIJZEL, E. L.
|
|
2006
|
4 |
9 |
p. 1975-1981
|
artikel
|
| 33 |
More on: platelet function analyser (PFA)-100® closure time in the evaluation of platelet disorders and platelet function
|
FAVALORO, E. J.
|
|
2006
|
4 |
9 |
p. 2099-2100
|
artikel
|
| 34 |
No evidence for an intrinsic platelet defect in patients with liver cirrhosis – studies under flow conditions
|
LISMAN, T.
|
|
2006
|
4 |
9 |
p. 2070-2072
|
artikel
|
| 35 |
Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura
|
TAO, Z.
|
|
2006
|
4 |
9 |
p. 1931-1935
|
artikel
|
| 36 |
Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications
|
CHAPMAN, W. C.
|
|
2006
|
4 |
9 |
p. 2083-2085
|
artikel
|
| 37 |
Plasma protein S activity correlates with protein S genotype but is not sensitive to identify K196E mutant carriers
|
KIMURA, R.
|
|
2006
|
4 |
9 |
p. 2010-2013
|
artikel
|
| 38 |
Platelet hyperreactivity generalizes to multiple forms of stimulation
|
YEE, D. L.
|
|
2006
|
4 |
9 |
p. 2043-2050
|
artikel
|
| 39 |
Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality
|
YOUNG, L.
|
|
2006
|
4 |
9 |
p. 1919-1924
|
artikel
|
| 40 |
Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi-center prospective study
|
KUWANA, M.
|
|
2006
|
4 |
9 |
p. 1936-1943
|
artikel
|
| 41 |
Prior use of antithrombotic agents and neurological functional outcome at discharge in patients with ischemic stroke
|
PACIARONI, M.
|
|
2006
|
4 |
9 |
p. 1957-1961
|
artikel
|
| 42 |
Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism
|
REICH, L. M.
|
|
2006
|
4 |
9 |
p. 1909-1913
|
artikel
|
| 43 |
Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation
|
ALTMAN, R.
|
|
2006
|
4 |
9 |
p. 2022-2027
|
artikel
|
| 44 |
Role of placental growth factor in glucose metabolism
|
VOROS, G.
|
|
2006
|
4 |
9 |
p. 2098-2099
|
artikel
|
| 45 |
Role of the P2Y12 gene polymorphism in platelet responsiveness to clopidogrel in healthy subjects
|
BURA, A.
|
|
2006
|
4 |
9 |
p. 2096-2097
|
artikel
|
| 46 |
Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study
|
VAN DER HAGEN, P. B.
|
|
2006
|
4 |
9 |
p. 1903-1908
|
artikel
|
| 47 |
Successful outcome of using recombinant activated factor VII (rFVIIa) in liver biopsy in a patient with liver failure
|
AL SOBHI, E.
|
|
2006
|
4 |
9 |
p. 2073-2074
|
artikel
|
| 48 |
The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells
|
SMADJA, D. M.
|
|
2006
|
4 |
9 |
p. 2051-2058
|
artikel
|
| 49 |
The metabolic syndrome and the risk of venous thrombosis: a case–control study
|
AGENO, W.
|
|
2006
|
4 |
9 |
p. 1914-1918
|
artikel
|
| 50 |
Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms
|
DENTALI, F.
|
|
2006
|
4 |
9 |
p. 1853-1863
|
artikel
|
| 51 |
Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats
|
VAN WESTERLOO, D. J.
|
|
2006
|
4 |
9 |
p. 1997-2002
|
artikel
|
| 52 |
Venous thromboembolism and atherosclerosis: common denominators or different diseases?
|
AGNELLI, G.
|
|
2006
|
4 |
9 |
p. 1886-1890
|
artikel
|
| 53 |
Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis
|
PRANDONI, P.
|
|
2006
|
4 |
9 |
p. 1891-1896
|
artikel
|
| 54 |
von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M
|
BARONCIANI, L.
|
|
2006
|
4 |
9 |
p. 2088-2090
|
artikel
|
| 55 |
Why should statins prevent venous thromboembolism? A systematic literature search and a call for action
|
SQUIZZATO, A.
|
|
2006
|
4 |
9 |
p. 1925-1927
|
artikel
|
Tijdschrift beschrijving